Brent Sabatini, the Senior Vice President and Chief Accounting Officer at Vir Biotechnology, Inc. (NASDAQ:VIR), recently sold 1,562 shares of the company's common stock. According to InvestingPro data ...

Researchers say study provides sufficient rationale to further explore the therapeutic uses of SSRIs during infection.

Researchers say study provides sufficient rationale to further explore the therapeutic uses of SSRIs during infection.

Varshavski: I asked a bunch of different specialists what's the one medical breakthrough they're excited about in their ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

Operator: Thank you for standing by, and welcome to the Origin Agritech Fiscal Year 2024 Conference Call. Please note that, today ...

JMP Securities reaffirmed their market outperform rating on shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) in a report released on Tuesday,Benzinga reports. JMP Securities currently has ...

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) has received an average recommendation of “Moderate Buy” from the six ratings firms that are covering the stock, Marketbeat reports. One ...

Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...

Virginia Tech is leading the effort that aims to strengthen bonds between biomedical companies and sector leaders.

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...